USD-ETT for Airway Management
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether a new type of breathing tube, visible with ultrasound, helps doctors place it more accurately. The goal is to ensure the tube reaches the correct position and depth when a patient undergoes anesthesia for heart procedures. Individuals scheduled for a heart procedure with general anesthesia who require a breathing tube may be suitable candidates for this trial.
As an unphased trial, this study allows patients to contribute to advancements in medical procedures and improve outcomes for future heart surgery patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this device is safe for airway management?
Research shows that ultrasound technology can help place breathing tubes more accurately. Studies have found that ultrasound can confirm correct tube placement and quickly identify any errors.
The ultrasound-detectable endotracheal tube (USD-ETT) aims to improve this process. Although specific safety reports for this device are not yet available, ultrasound is widely used and well-tolerated in medical settings, including airway management.
Labeling the trial as "Not Applicable" for phases likely indicates it tests the device's effectiveness rather than its safety. Since ultrasound is already a trusted tool in healthcare, the USD-ETT should be safe to try.12345Why are researchers excited about this trial?
Researchers are excited about the ultrasound-detectable endotracheal tube (USD-ETT) because it offers a new way to manage airways with greater precision. Unlike traditional endotracheal tubes, which rely on X-rays or manual checks, the USD-ETT can be easily identified using ultrasound. This feature allows for quicker and more accurate positioning, minimizing potential complications during intubation. Additionally, the use of ultrasound reduces exposure to radiation, making the procedure safer for both patients and medical staff.
What evidence suggests that this device is effective for airway management?
Research has shown that ultrasound, which uses sound waves to create images, can effectively confirm the correct placement of a breathing tube, especially in challenging situations like cardiac arrest. Studies have found that ultrasound excels at detecting when a tube mistakenly enters the esophagus, rather than the trachea. This helps prevent serious complications by ensuring the tube is correctly placed in the windpipe. In this trial, participants will receive an ultrasound-detectable endotracheal tube (USD-ETT), designed for easier visualization with ultrasound, ensuring more accurate placement. This could enhance the safety and reliability of breathing tube insertion.13678
Who Is on the Research Team?
John Charpie, MD, PhD
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for patients scheduled for cardiac catheterization needing general anesthesia with endotracheal intubation. It's not suitable for those with tracheostomies, allergies to the tube materials, airway abnormalities, or who are already intubated or enrolled in another trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Intubation with a novel ultrasound-detectable endotracheal tube (USD-ETT) and assessment of tube placement using ultrasound and fluoroscopy
Follow-up
Participants are monitored for safety and effectiveness after intubation, including assessment of ventilation and oxygenation
What Are the Treatments Tested in This Trial?
Interventions
- Ultrasound-detectable Endotracheal Tube
Find a Clinic Near You
Who Is Running the Clinical Trial?
John R. Charpie
Lead Sponsor